Dec 06, 2019 - Regeneron (REGN) announces positive top-line data from a phase II study on rare blood disorder drug.
Dec 03, 2019 - Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Piper Jaffray 31st Annual Healthcare Conference Call December 3, 2019 08:00 a.m. ET Company Representatives Bob Landry - Chief Financial Officer Justin Ho
Nov 29, 2019 - Alnylam (ALNY) gets FDA approval for givosiran injection for subcutaneous use to treat adults with acute hepatic porphyria. Givosiran injection will be marketed by the trade name of Givlaari.
Nov 28, 2019 - REGN vs. BMRN: Which Stock Is the Better Value Option?
Nov 19, 2019 - We highlight a few principal players from the biotech sector, which are likely to witness a winning run in the near term.
Nov 14, 2019 - GlaxoSmithKline's (GSK) late-stage study evaluating Nucala succeeds in reducing flares in patients with Hypereosinophilic Syndrome.
Nov 12, 2019 - REGN vs. BMRN: Which Stock Is the Better Value Option?
Nov 11, 2019 - Celgene (CELG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Nov 07, 2019 - Top Stock Reports for Alibaba, General Electric & Anthem
Nov 05, 2019 - REGN earnings call for the period ending September 30, 2019.